Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 28-Aug-24 4:34 PM View:  | 23andme Holding Co. (VGAC) | 26-Aug-24 | Grant | 658,485 | -- | -- | 277% 237.48K to 895.96K | |
| 23-Aug-24 4:05 PM View: | Alector, Inc. (ALEC) | 22-Aug-24 | Sale | 44,250 | $5.16 | $228,388.00 | (56%) 79.25K to 35.0K | |
| 10-Oct-24 4:05 PM View: | Alector, Inc. (ALEC) | 02-Aug-24 | Grant | 15,833 | -- | -- | 45% 35.0K to 50.83K | |
| 12-Jun-24 4:46 PM View: | Alector, Inc. (ALEC) | 12-Jun-24 | Grant | 35,000 | -- | -- | 79% 44.25K to 79.25K | |
| 08-Sep-23 4:57 PM View: | 23andme Holding Co. (VGAC) | 06-Sep-23 | Grant | 165,088 | -- | -- | 228% 72.39K to 237.48K | |
| 09-Aug-23 4:29 PM View: | Dice Therapeutics, Inc. (DICE) | 09-Aug-23 | Disposition | 8,427 | -- | -- | (100%) 8.43K to 0 | |
| 14-Feb-24 5:58 PM View: | Alector, Inc. (ALEC) | 15-Jul-23 | Grant | 8,541 | -- | -- | 24% 35.71K to 44.25K | |
| 15-Jun-23 4:02 PM View: | Alector, Inc. (ALEC) | 14-Jun-23 | Grant | 26,250 | -- | -- | 278% 9.46K to 35.71K | |
| 09-May-23 6:02 PM View: | Dice Therapeutics, Inc. (DICE) | 05-May-23 | Private Sale (Planned) | 84,097 | $38.51 | $3,238,210.00 | (91%) 92.52K to 8.43K | |
| 21-Feb-23 8:21 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Feb-23 | Payment of Exercise | 1,304 | $12.64 | $16,482.60 | (2%) 55.13K to 53.82K | |
| 21-Feb-23 8:21 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Feb-23 | Option Exercise | 3,196 | -- | -- | 6% 51.93K to 55.13K | |
| 18-Nov-22 6:38 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Nov-22 | Payment of Exercise | 1,106 | $9.64 | $10,661.80 | (2%) 53.04K to 51.93K | |
| 18-Nov-22 6:38 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Nov-22 | Option Exercise | 3,196 | -- | -- | 6% 49.84K to 53.04K | |
| 14-Nov-22 4:38 PM View: | 23andme Holding Co. (VGAC) | 11-Nov-22 | Sale | 18,421 | $3.24 | $59,684.00 | (20%) 90.81K to 72.39K | |
| 08-Sep-22 4:47 PM View: | 23andme Holding Co. (VGAC) | 06-Sep-22 | Grant | 14,633 | -- | -- | 19% 76.18K to 90.81K | |
| 29-Aug-22 4:29 PM View: | 23andme Holding Co. (VGAC) | 25-Aug-22 | Grant | 57,755 | -- | -- | 314% 18.42K to 76.18K | |
| 18-Aug-22 6:35 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Aug-22 | Payment of Exercise | 1,101 | $11.08 | $12,199.10 | (2%) 50.94K to 49.84K | |
| 18-Aug-22 6:35 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Aug-22 | Option Exercise | 3,196 | -- | -- | 7% 47.74K to 50.94K | |
| 21-Jun-22 8:06 PM View: | Alector, Inc. (ALEC) | 16-Jun-22 | Grant | 9,459 | -- | -- | 100% 0 to 9.46K | |
| 18-May-22 4:09 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-May-22 | Payment of Exercise | 1,310 | $6.74 | $8,829.40 | (3%) 49.05K to 47.74K | |
| 18-May-22 4:09 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-May-22 | Option Exercise | 3,195 | -- | -- | 7% 45.86K to 49.05K | |
| 16-Sep-21 10:00 PM View: | 23andme Holding Co. (VGAC) | 14-Sep-21 | Grant | 18,421 | -- | -- | 100% 0 to 18.42K | |
| 09-Aug-21 6:13 PM View: | Alector, Inc. (ALEC) | 05-Aug-21 | Option Exercise | 56,260 | $10.14 | $570,476.00 | 100% 0 to 56.26K | |
| 09-Aug-21 6:13 PM View: | Alector, Inc. (ALEC) | 05-Aug-21 | Market Option Sale | 46,279 | $27.68 | $1,281,060.00 | (82%) 56.26K to 9.98K | |
| 09-Aug-21 6:13 PM View: | Alector, Inc. (ALEC) | 05-Aug-21 | Market Sale | 9,981 | $27.68 | $276,286.00 | (100%) 9.98K to 0 | |
| 06-Aug-21 6:08 PM View: | Bridgebio Pharma, Inc. (BBIO) | 04-Aug-21 | Option Exercise | 13,777 | $17.00 | $234,209.00 | 30% 45.86K to 59.64K | |
| 06-Aug-21 6:08 PM View: | Bridgebio Pharma, Inc. (BBIO) | 04-Aug-21 | Market Option Sale | 13,777 | $53.23 | $733,317.00 | (23%) 59.64K to 45.86K | |
| 09-Aug-21 6:13 PM View: | Alector, Inc. (ALEC) | 02-Jul-21 | Planned Option Sale | 9,981 | $31.14 | $310,808.00 | (100%) 9.98K to 0 | |
| 24-May-21 7:29 PM View: | Oric Pharmaceuticals, Inc. (ORIC) | 24-May-21 | Market Sale (Planned) | 100 | $25.00 | $2,500.00 | (< 1%) 39.19K to 39.09K | 1% |
| 24-May-21 7:29 PM View: | Oric Pharmaceuticals, Inc. (ORIC) | 21-May-21 | Market Sale (Planned) | 1,231 | $25.19 | $31,008.30 | (3%) 40.42K to 39.19K | 2% |
| 24-May-21 7:29 PM View: | Oric Pharmaceuticals, Inc. (ORIC) | 20-May-21 | Market Sale (Planned) | 659 | $25.08 | $16,528.00 | (2%) 41.08K to 40.42K | 2% |
| 18-May-21 8:20 PM View: | Oric Pharmaceuticals, Inc. (ORIC) | 18-May-21 | Market Sale (Planned) | 2,800 | $25.34 | $70,958.20 | (6%) 43.88K to 41.08K | 3% |
| 18-May-21 8:20 PM View: | Oric Pharmaceuticals, Inc. (ORIC) | 17-May-21 | Market Sale (Planned) | 500 | $25.06 | $12,530.10 | (1%) 44.38K to 43.88K | 2% |
| 18-May-21 8:20 PM View: | Oric Pharmaceuticals, Inc. (ORIC) | 14-May-21 | Market Sale (Planned) | 4,615 | $25.38 | $117,117.00 | (9%) 49.0K to 44.38K | 3% |
| 13-May-21 7:59 PM View: | Oric Pharmaceuticals, Inc. (ORIC) | 13-May-21 | Market Sale (Planned) | 100 | $25.00 | $2,500.00 | (< 1%) 49.1K to 49.0K | 1% |
| 13-May-21 7:59 PM View: | Oric Pharmaceuticals, Inc. (ORIC) | 12-May-21 | Market Sale (Planned) | 103 | $25.00 | $2,575.39 | (< 1%) 49.2K to 49.1K | 1% |
| 13-May-21 7:59 PM View: | Oric Pharmaceuticals, Inc. (ORIC) | 11-May-21 | Market Sale (Planned) | 300 | $25.16 | $7,547.88 | (< 1%) 49.5K to 49.2K | 2% |
| 30-Apr-21 7:57 PM View: | Oric Pharmaceuticals, Inc. (ORIC) | 30-Apr-21 | Market Sale (Planned) | 100 | $25.19 | $2,519.00 | (< 1%) 49.6K to 49.5K | 2% |
| 30-Apr-21 7:57 PM View: | Oric Pharmaceuticals, Inc. (ORIC) | 28-Apr-21 | Market Sale (Planned) | 200 | $25.11 | $5,022.00 | (< 1%) 49.8K to 49.6K | 2% |
| 05-Apr-21 7:45 PM View: | Oric Pharmaceuticals, Inc. (ORIC) | 01-Apr-21 | Private Sale (Planned) | 200 | $25.00 | $5,000.00 | (< 1%) 50.0K to 49.8K | |
| 23-Dec-20 5:35 PM View: | Bridgebio Pharma, Inc. (BBIO) | 21-Dec-20 | Sale | 60,401 | $65.32 | $3,945,140.00 | (57%) 106.26K to 45.86K | |
| 21-Dec-20 4:05 PM View: | Bridgebio Pharma, Inc. (BBIO) | 18-Dec-20 | Sale | 30,000 | $65.07 | $1,952,020.00 | (22%) 136.26K to 106.26K | |
| 17-Dec-20 4:05 PM View: | Bridgebio Pharma, Inc. (BBIO) | 15-Dec-20 | Option Exercise | 29,277 | $17.00 | $497,709.00 | 21% 138.43K to 167.7K | |
| 17-Dec-20 4:05 PM View: | Bridgebio Pharma, Inc. (BBIO) | 15-Dec-20 | Option Sale | 29,277 | $60.38 | $1,767,640.00 | (17%) 167.7K to 138.43K | |
| 17-Dec-20 4:05 PM View: | Bridgebio Pharma, Inc. (BBIO) | 15-Dec-20 | Sale | 2,166 | $60.38 | $130,775.00 | (2%) 138.43K to 136.26K | |
| 18-Sep-20 4:05 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Sep-20 | Sale (Planned) | 25,000 | $37.50 | $937,500.00 | (15%) 163.43K to 138.43K | |
| 28-Apr-20 5:09 PM View: | Oric Pharmaceuticals, Inc. (ORIC) | 28-Apr-20 | Conversion | 25,000 | -- | -- | 100% 25.0K to 50.0K | |
| 06-Feb-20 5:19 PM View: | Alector, Inc. (ALEC) | 04-Feb-20 | Market Sale (Planned) | 10,000 | $29.67 | $296,700.00 | (50%) 19.98K to 9.98K | 44% |
| 03-Jul-19 4:17 PM View: | Bridgebio Pharma, Inc. (BBIO) | 01-Jul-19 | Option Exercise | 163,427 | -- | -- | 100% 0 to 163.43K | |
| 14-Aug-17 6:07 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 10-Aug-17 | Market Purchase | 7,000 | $2.85 | $19,950.00 | 100% 0 to 7.0K | 101% |